12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Melphalan delivered via Delcath's PHP system: Phase III data

An open-label Phase III trial in 92 patients showed that melphalan delivered via Delcath's PHP system for the regional delivery of the drug to the liver met the primary endpoint of significantly increasing median hPFS vs. best alternative care (214...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >